ENDEAVOR

Striving to improve the quality of life of Barrett’s Esophagus patients.

Find out more about our research
For Patients
For Researchers
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more
Endeavor-784x624-01

Welcome

WHAT is the ENDEAVOR research project?

ENDEAVOR is an EU-funded research project of 5 years carried out by a consortium of 15 academic partners, 2 general hospitals and 2 industrial partners. It aims to implement an innovative risk stratification method: we want to better determine which Barrett’s esophagus (BE) patients are at risk to develop more invasive cancer and may poorly respond to endoscopic therapy. Like that, we will be able to direct the best treatment and select the most optimal subsequent surveillance program for each patient.

Read more

Funded by the European Union

The Endeavor research project has received funding from the European Union’s Horizon EU research and innovation programme under grant agreement number: 101136935*.

* Disclaimer: “Funded by the European Union. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.”

Depositphotos_685111902_S-784

Endeavor EU Follow

ENDEAVOR is an EU-funded research project aiming to improve the quality of life and care of patients with Barrett's Esophagus in Europe #EUfunded #HorizonEU

EndeavorEU
endeavoreu Endeavor EU @endeavoreu ·
10 Jun

Meet the Endeavor PhD students! 💥

👀Happy to introduce Jennifer Kluczny, PhD candidate at HHU, Germany.

🔍 Jennifer focuses on identifying new molecular markers via single cell sequencing to identify patients at high risk of esophageal cancer (recurrence).

#HorizonEU

Reply on Twitter 1932320575080550703 Retweet on Twitter 1932320575080550703 Like on Twitter 1932320575080550703 Twitter 1932320575080550703
endeavoreu Endeavor EU @endeavoreu ·
2 Jun

Meet the Endeavor PhD students! 💥

👀Happy to introduce @MartinWyckmans, PhD candidate at Antwerp University.

🔍 Martin will explore how clonal diversity affects cancer recurrence in Barrett’s esophagus by analzying esophageal tissue biopsies.

#EndeavorEU #HorizonEU #PhD

Reply on Twitter 1929421471262118114 Retweet on Twitter 1929421471262118114 Like on Twitter 1929421471262118114 1 Twitter 1929421471262118114
endeavoreu Endeavor EU @endeavoreu ·
26 May

Meet the Endeavor PhD students! 💥

Happy to introduce our PhD candidates Henrik, Nastaran, Jennifer, Piotr, Costanza, Martin and Laser.

Stay tuned to find our more about each student and their interesting projects! 👀

#EUfunded #EndeavorEU #PhDcandidates #HorizonEU

Reply on Twitter 1926881112267145411 Retweet on Twitter 1926881112267145411 1 Like on Twitter 1926881112267145411 2 Twitter 1926881112267145411
endeavoreu Endeavor EU @endeavoreu ·
15 Apr

We've had a wonderful annual meeting in Ireland last weekend. Thank you to all our #EndeavorEU consortium partners and the members of our #PPI panel for joining us and providing us with your invaluable feedback!

And thank you to @HorizonEU for enabling this #EUcollaboration!🤝

Reply on Twitter 1912042010619392227 Retweet on Twitter 1912042010619392227 3 Like on Twitter 1912042010619392227 6 Twitter 1912042010619392227
Load More